Hgb 206: A Phase I Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo with the LentiGlobin BB305 Lentiviral Vector in Subjects with Severe Sickle Cell Disease

Project: Research project

Project Details

StatusActive
Effective start/end date7/15/158/31/50

Funding

  • Bluebird Bio, Inc.